Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22010830 | 0.82 | NUAK1 (0.33) | KDM4E | |
| SCHEMBL20828961 | 0.78 | PGAM1 (0.34) | KDM4EMEN1MAPTKMT2A | |
| SCHEMBL16871067 | 0.73 | HSD17B3 (0.33) | — | |
| SCHEMBL25583308 | 0.70 | ALDH1A1 (0.44) | KDM4EMEN1MAPTKMT2A | |
| SCHEMBL14523541 | 0.70 | NQO1 (0.38) | KDM4EMEN1MAPTKMT2AAHR | |
| SCHEMBL16871068 | 0.68 | — | — | |
| SCHEMBL21379597 | 0.67 | HSD17B3 (0.46) | KDM4EMEN1MAPTKMT2A | |
| SCHEMBL16871097 | 0.65 | HSD17B3 (0.32) | KDM4EMAPT | |
| SCHEMBL5986942 | 0.64 | ALDH1A1 (0.47) | KDM4EMEN1KMT2A | |
| SCHEMBL20927284 | 0.63 | RAB9A (0.40) | MEN1MAPTKMT2AAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | YBX1, ZKSCAN2, RCC1 | KDM4E 2962/4885MEN1 2633/4885MAPT 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.